- HOME
- 会長挨拶
- 開催概要
- New
- 会場のご案内
- 協賛のご案内
-
Call for Abstracts
- 指定演題登録
- New
- New
-
事前参加登録
(マイページログイン) -
演題登録
(ログインページ)
ログイン・マイページProgram
-
Chairman's speech2024/06/01 (Saturday) 13:30ー14:001st venue (5th floor International Conference Room)
- Chairpersons
-
Masahiro Abe（Kawashima Hospital）
- Speakers
-
Yasushi Takamatsu（Medical Oncology, Hematology and Infectious Diseases, Dept. of Internal Medicine, Fukuoka University）
-
International Symposium
【English Session】
2024/06/01 (Saturday) 10:40ー11:501st venue (5th floor International Conference Room)- Chairpersons
-
Hiroshi Kosugi（Dept. of Hematology, Ogaki Municipal Hospital）
Shinsuke Iida（Dept. of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences）
「Current status and future prospects of treatment for myeloma - regarding the risk-adapted therapy」- Speakers
-
Shuji Ozaki（Tokushima Prefectural Central Hospital Dept. of Hematology）
「Current therapeutic options and the clinical outcomes of myeloma in Korea」- Speakers
-
Jin Seok Kim（Division of Hematology, Dept. of Internal Medicine, Yonsei University College of Medicine/Korean Multiple Myeloma Working Party）
「Prospects for future treatment strategy for myeloma, especially regarding the risk adapted therapy」- Speakers
-
Philippe Moreau（International Myeloma Society/Clinical Hematology, the University Hospital of Nantes/Translational Research Program in Hematology and Oncology, the University Hospital of Nante）
-
Symposium
Symposium 1 「Therapies targeting the immune microenvironment」
【English Session】
2024/06/01 (Saturday) 09:00ー10:301st venue (5th floor International Conference Room)- Chairpersons
-
Hideto Tamura（Division of Diabetes, Endocrinology and Hematology, Dept. of Internal Medicine, Dokkyo Medical University Saitama Medical Center）
Michiko Ichii（Osaka University Graduate School of Medicine, Dept. of Hematology and Oncology）
「The role of tumor microenvironment in myeloma treatment」- Speakers
-
Michiko Ichii（Osaka University Graduate School of Medicine, Dept. of Hematology and Oncology）
- Speakers
-
Nikhil Munshi（Harvard Medical School, Dana-Farber Cancer Institute）
- Speakers
-
Gareth Morgan（New York University Langone）
「Mechanisms of impairment of therapeutic efficacy of BCMA-targeting immunotherapies by osteoclasts」- Speakers
-
Harada Takeshi（Dept. of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences）
Symposium 2 「Control and prevention of infectious diseases」2024/06/01 (Saturday) 09:00ー10:30Venue 3 (4th floor 411/412)- Chairpersons
-
Kazuki Tanimoto（Dept. of Hematology and Oncology, Japanese Red Cross Fukuoka Hospital ）
Tomohiko Kamimura（Dept. of Hematology,Hara Sanshin Hospital）
「Management of infectious diseases in patients with multiple myeloma」- Speakers
-
Yoshihiro Eriguchi（Kyushu University Hospital, Dept. of Clinical Immunology and Rheumatology/Infectious Disease）
「Management for bacterial infection in myeloma」- Speakers
-
Kazuhito Suzuki（The Jikei University School of Medicine, Division of Clinical Oncology and Hematology）
「Management of fungal infections in multiple myeloma」- Speakers
-
Kentaro Serizawa（Dept. of Hematology and Rheumatology, Faculty of Medicine, Kindai University）
「Viral infections in patients with multiple myeloma in the novel agent era: focus on herpes simplex virus, varicella-zoster virus, and cytomegalovirus」- Speakers
-
Masuho Saburi（Oita Prefectural Hospital Dept. of Hematology）
Symposium 3 「New treatments（CAR-T/bispecific antibody）」
【English Session】
2024/06/01 (Saturday) 14:10ー15:401st venue (5th floor International Conference Room)- Chairpersons
-
Tadao Ishida（Dept. of Hematology,Japanese Red Cross Medical Center）
Junya Kuroda（Division of Hematology and Oncology,Kyoto Prefectural University of Medicine Graduate School of Medical Science,Japan）
「Idecabtagene Vicleucel (ide-cel) vs Standard Regimens (SR) in Patients (pts) with TCE RRMM: Updated KarMMa-3 Analysis」- Speakers
-
Shinsuke Iida（Dept. of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences）
「Infectious complications of bispecific antibodies for multiple myeloma treatment」- Speakers
-
Ja Min Byun（Seoul National University Hospital）
「Overview of bispecific antibody therapy in relapsed/refractory multiple myeloma」- Speakers
-
Mohamad Mohty（Sorbone University, Saint-Antoine Hospital）
「Overview of CAR-T therapy」- Speakers
-
Nikhil Munshi（Harvard Medical School, Dana-Farber Cancer Institute）
Symposium 4 「Elderly & Rehabilitation」2024/06/01 (Saturday) 14:10ー15:40Venue 3 (4th floor 411/412)- Chairpersons
-
Hidenori Sasaki（Dept. of Oncology, Hematology, and Infectious Diseases,Fukuoka University Hospital）
Satoshi Kamada（Dept. of Rehabilitationt,Fukuoka University Hospital）
「The Necessity of Geriatric Assessments and Frailty Scores for Tailored Therapy in Multiple Myeloma Patients」- Speakers
-
Ji Yun Lee（Dept. of Internal Medicine,Seoul National University Bundang Hospital）
「GNRI (Geriatric Nutritional Risk Index) in elderly patients with multiple myeloma」- Speakers
-
Kazuhito Suzuki（The Jikei University School of Medicine, Division of Clinical Oncology and Hematology）
「Enhancing Patient Care: Integrating Geriatric Assessments for Patients with Multiple Myeloma」- Speakers
-
Shohei Togashi （Dept. of Rehabilitation National Hospital Organization Hiroshima-Nishi Medical Center）
「Management of elderly myeloma or metastatic bone tumor patients」- Speakers
-
Satoshi Kamada（Fukuoka University Hospital Dept. of Rehabilitation）
「Discharge Support Hospital’s Efforts to Support the Discharge of Myeloma Patients」- Speakers
-
Yoshiki Yamaguchi（Murakamikarindoh Hospital）
「Discharge Support for Patients at High Risk of Pathological Fracture through Multidisciplinary Collaboration」- Speakers
-
Shohei Sakamoto（Hakujyuji Hospital）
Symposium 5 「Therapeutic management of bone lesions」2024/06/02 (Sunday) 9:00ー10:301st venue (5th floor International Conference Room)- Chairpersons
-
Takeshi Harada （Dept. of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences）
Yuichi Horigome（Dept. of Hematology, Kitasato University Hospital）
「MM-bone interaction: from pathogenesis to treatment」- Speakers
-
Takeshi Harada（Dept. of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences）
「Treatment of painful vertebral body fracture in patient with multiple myeloma : The orthopedic surgeon’s perspective.」- Speakers
-
Hidetake Matsuzaki（National Hospital Organization Disaster Medical Center Dept. of Orthopedic surgery）
「Imaging diagnosis of bone lesions in multiple myeloma」- Speakers
-
Miyuki Takasu（Dept. of Diagnostic Radiology, Hiroshima City Hiroshima Citizens Hospital）
「Rehabilitation for patients with neoplastic bone lesions」- Speakers
-
Akira Kido（Nara Medical University, Dept. of Rehabilitation Medicine）
Symposium 6 「Multi-professional collaboration and team medical care」2024/06/02 (Sunday) 9:00ー10:50Venue 3 (4th floor 411/412)- Chairpersons
-
Naoaki Nishimura（Dept. of Pharmacy, JCHO Kyushu Hospital ）
Ilseung Choi（Dept. of Hematology, National Hospital Organization,Kyushu Cancer Center）
「Interprofessional collaboration for team medical care to patients during hospitalization and outpatient care after discharge」- Speakers
-
Noriko Yokota（Dept. of Nursing, Harasanshin Hospital）
「Advanced Medication Management and Patient Support in Multiple Myeloma Treatment」- Speakers
-
Masato Komuro（Center Hospital of the National Center for Global Health and Medicine Center for Medical Informatics Intelligence）
「The involvement of hospital pharmacists in transitioning from inpatient to outpatient treatment.」- Speakers
-
Tomoaki Eto（NHO Kyushu Cancer Center, Department of Pharmacy）
「Collaboration regarding home care」- Speakers
-
Naoko Ishibashi（Fukuoka Red Cross Hospital）
「Roles of specialized hematology clinics in regional hematology care」- Speakers
-
Kensuke Ohta（Medical Corporation LIGARE, Hematology Ohta Clinic, Shinsaibashi）
-
Educational Seminar2024/06/02 (Sunday) 13:00ー13:40Venue 3 (4th floor 411/412)
- Chairpersons
-
Yoshiaki Kuroda（Dept. of Hematology, National Hospital Organization Hiroshima-Nishi Medical Center）
Shinichi Fuchida（JCHO Kyoto Kuramaguchi Medical Center）
「Biological and clinical features of proteasome inhibitors and management of adverse effects」- Speakers
-
Shigeki Ito（Hematology & Oncology, Dept. of Internal Medicine, Iwate Medical University School of Medicine）
「Immunomodulatory drugs (IMiDs) in multiple myeloma : characteristics, and management of the adverse event」- Speakers
-
Emiko Sakaida（Dept. of Hematology, Chiba University Hospital）
-
Patient and Public Involvement Program2024/06/02 (Sunday) 14:00ー15:30Venue 3 (4th floor 411/412)「Promoting shared decision making for patients to live well with myeloma」
- 司 会
-
Yasushi Takamatsu（Medical Oncology, Hematology and Infectious Diseases, Dept. of Internal Medicine, Fukuoka University）
Sachiko Shibata（Myeloma Patients and Families Association Fukuoka Orison）
「Why is shared decision making important?」- Speakers
-
Yasushi Takamatsu（Medical Oncology, Hematology and Infectious Diseases, Dept. of Internal Medicine, Fukuoka University）
「Results of survey for myeloma patients and their families.」- Speakers
-
Sachiko Shibata（Myeloma Patients and Families Association Fukuoka Orison）
「What do patients expect? From the point of view of patients receiving treatment for myeloma.」- Speakers
-
Yasuo Houri（Myeloma Patients and Families Association Fukuoka Orison）
- Speakers
-
Noriko Matsuura（Hamakko (Multiple Myeloma Patients and Families Meeting)）
「Activities of patient associations and patient support groups.」- Speakers
-
Akiko Ikeda（NPO CancerNet Japan/(Hamakko (Multiple Myeloma Patients and Families Meeting)）
「General discussion」 -
Plenary Session2024/06/02 (Sunday) 15:40ー16:40Venue 1 (International Conference Room, 5th floor)
- Chairpersons
-
Masahiro Abe（Kawashima Hospital）
Chiaki Nakaseko（International University of Health and Welfare School of Medicine, Dept. of Hematology）
「Development of off-the-shelf anti-CD38-CAR-T therapy using iPS-derived cytotoxic T cells for the treatment of myeloma」- Speakers
-
Yuji Hattori（Fujita Health University International Center for Cell and Gene Therapy）
「IL-6-induced ELL2 governs myeloma transcriptional program」- Speakers
-
Hiroto Ohguchi （Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University）
「Understanding the structure of the microenvironments in multiple myeloma with a focus on blood vessels」- Speakers
-
Kensuke Hachiya （Dept. of Signal Transduction, Research Institute for Microbial Diseases, Osaka University）
「Analysis of circulating plasma cells (CPCs) in smoldering multiple myeloma and MGUS patients」- Speakers
-
Atsushi Uehara（Kameda Medical Center, Dept. of Hematology and Oncology）
「Retrospective analysis of the incidence of herpes zoster and the patients' backgrounds in transplant-ineligible NDMM patients receiving D-Rd」- Speakers
-
Yuichi Horigome （Dept. of Hematology, Kitasato University Hospital）
-
Oral PresentationOral Presentation 1 「Basic and Clinical Research 1」2024/06/01 (Saturday) 10:40ー11:50Venue 3 (4th floor 411/412)
- Chairpersons
-
Yutaka Hattori（Keikokai Medical Corp P-one Clinic）
Akira Sakai（Dept. of Radiation Life Sciences,Fukushima Medical University School of Medicine ）
Oral Presentation 2 「Basic and Clinical Research 2」2024/06/02 (Sunday) 10:40ー11:50Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Hiroshi Handa（Gunma University Graduate School of Medicine, Dept. of Hematology）
Yoichi Imai（Dept. of Hematology and Oncology,Dokkyo Medical University,Japan）
Oral Presentation 3 「Multi-professional collaboration」2024/06/02 (Sunday) 11:00ー11:50Venue 3 (4th floor 411/412)- Chairpersons
-
Yasuhito Terui（Dept. of Hematology, Saitama Medical University Hospital）
Ryosuke Ogawa（Dept. of Hematology and Oncology,JCHO Kyushu Hospital ）
Oral Presentation 4 「Treatment」2024/06/02 (Sunday) 14:00ー15:301st venue (5th floor International Conference Room)- Chairpersons
-
Hirohiko Shibayama（Dept. of Hematology,National Hospital Organization Osaka National Hospital）
Kazutaka Sunami（Dept. of Hematology, NHO Okayama National Hospitall）
-
Poster Session2024/06/01 (Saturday) 18:00ー19:00Poster venue (4th floor 409/410)
-
Sponsored SeminarMorning Seminar 12024/06/02 (Sunday) 8:10ー8:50Venue 1 (International Conference Room, 5th floor)
- Chairpersons
-
Mineo Kurokawa（Dept. of Hematology & Oncology,Graduate School of Medicine, The University of Tokyo）
「Pitfalls of M protein Detection by Immunofixation in plasma cell dyscrasias.」- Speakers
-
Yawara Kawano（Kumamoto University Hospital, Dept. of Hematology, Rheumatology, and Infectious Diseases）
- Co-hosting
- SEBIA JAPAN Co., Ltd.
Morning Seminar 22024/06/02 (Sunday) 8:10ー8:502nd venue (5th floor 502/503)- Chairpersons
-
Masaki Iino（Yamanashi Prefectural Central Hospital）
「The Importance of Minimal Residual Disease (MRD) Analysis in Myeloma Treatment in the Immunotherapy Era- Focusing on the characteristics and usefulness of Multicolor 10 -」- Speakers
-
Yoichi Imai （Dept. of Hematology and Oncology, Dokkyo Medical University）
- Co-hosting
- LSI Medience Corporation
Morning Seminar 32024/06/02 (Sunday) 8:10ー8:50Venue 3 (4th floor 411/412)- Chairpersons
-
Kensuke Ohta （LIGARE Hematology Ohta Clinic,Shinsaibashi Hematology）
「The importance of achieving well-being for multiple myeloma patients and the significance of maintenance therapy」- Speakers
-
Ryosuke Ogawa（Dept. of Hematology and Oncology,JCHO Kyushu Hospital）
- Speakers
-
takashi Ikeda（Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan）
- Co-hosting
- Takeda Pharmaceutical Company Limited
Luncheon Seminar 12024/06/01 (Saturday) 12:00ー12:50Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Ichiro Hanamura（Division of Hematology.Dept. of Internal Medicine,Aichi Medical University,Japan）
「Clinical Landscape and Future Horizons in Multiple Myeloma Therapy: Advancing from MAIA and ALCYONE」- Speakers
-
Taku Kikuchi（Japanese Red Cross Medical Center）
- Co-hosting
- Janssen Pharmaceutical K.K.
Luncheon Seminar 22024/06/01 (Saturday) 12:00ー12:502nd venue (5th floor 502/503)- Chairpersons
-
Naoki Hosen（Dept. of Hematology and Oncology, Osaka University Graduate School of Medicine）
「Future Treatment Landscape of multiple myeloma」- Speakers
-
Tadao Ishida（Dept. of Hematology, Japanese Red Cross Medical Center）
- Co-hosting
- AbbVie GK
Luncheon Seminar 32024/06/01 (Saturday) 12:00ー12:50Venue 3 (4th floor 411/412)- Chairpersons
-
Koji Nagafuji（Division of Hematology and Oncology, Dept. of Medicine,Kurume University School of Medicine.）
「Significance of SARS-CoV-2 infection in clinical setting in patients with hematologic malignancies」- Speakers
-
Akihiro Tomita（Fujita Health University Dept. of Hematology）
- Co-hosting
- AstraZeneca K.K.
Luncheon Seminar 42024/06/02 (Sunday) 12:00ー12:50Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Hiroshi Handa（Gunma University Graduate School of Medicine, Dept. of Hematology）
「New options for treatment of relapsed or refractory multiple myeloma (RRMM)」- Speakers
-
Sunami Kazutaka（Dept. of Hematology, NHO Okayama National Hospitall）
- Co-hosting
- Pfizer Japan
Luncheon Seminar 52024/06/02 (Sunday) 12:00ー12:502nd venue (5th floor 502/503)- Chairpersons
-
Yasushi Isobe（Medical Oncology, Hematology and Infectious Diseases, Dept. of Internal Medicine, Fukuoka University）
「Secondary hypogammaglobulinemia and infection prevention in patients with multiple myeloma -The significance of immunoglobulin replacement therapy－」- Speakers
-
Yoshiaki Kuroda（Dept. of Hematology and Oncology NHO Hiroshimanishi Medical Center）
- Co-hosting
- CSL Behring K.K.
Luncheon Seminar 62024/06/02 (Sunday) 12:00ー12:50Venue 3 (4th floor 411/412)- Chairpersons
-
Hirohiko Shibayama（Dept. of Hematology,National Hospital Organization Osaka National Hospital）
「Significance of monitoring serum free light chain in myeloma kidney and MGRS-associated renal lesions」- Speakers
-
Shinichi Mizuno（Japan Community Health care Organization Sendai Hospital, Dept. Nephrology）
- Co-hosting
- Thermo Fisher Scientific K.K.
Evening Seminar 12024/05/31 (Friday) 17:00ー17:50Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Masahiro Abe（Kawashima Hospital）
「Updates in RRMM: Evolving Treatment Strategies for Sequencing Immune-based Therapies」- Speakers
-
Nikhil Munshi（Harvard Medical School, Dana-Farber Cancer Institute）
- Co-hosting
- Bristol-Myers Squibb K.K.
Evening Seminar 22024/06/01 (Saturday) 17:00ー17:50Venue 1 (5th floor 502/503)- Chairpersons
-
Emiko Sakaida（Dept. of Hematology, Chiba University Hospital）
「Clinical significance of immune-based therapy and iMiDs sequences from the perspective of chromosomal abnormalities and immune microenvironment in multiple myeloma」- Speakers
-
Akihiro Kitadate（Dept. of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan）
「Optimal introduction of CAR-T therapy for triple-class exposed RRMM」- Speakers
-
Naoya Mimura（Dept. of Transfusion Medicine and Cell Therapy, Chiba University Hospital）
- Co-hosting
- Bristol-Myers Squibb K.K.
Evening Seminar 32024/06/01 (Saturday) 17:00ー17:502nd venue (5th floor 502/503)- Chairpersons
-
Junya Kuroda（Division of Hematology and Oncology,Kyoto Prefectural University of Medicine Graduate School of Medical Science,Japan）
「Treatment strategy for Waldenström’s macroglobulinemia in 2024 and future prospects」- Speakers
-
Naohiro Sekiguchi（Dept. of Hematology, National Hospital Organization Disaster Medical Center）
- Co-hosting
- ONO PHARMACEUTICAL CO., LTD.
Evening Seminar 42024/06/01 (Saturday) 17:00ー17:50Venue 3 (4th floor 411/412)- Chairpersons
-
Chihiro Shimazaki（JCHO Kyoto Kuramaguchi Medical Center,honorary director of the clinic）
「Rationale of using Isatuximab in second-line treatment: explaining Efficacy and Safety from Basic and Clinical Perspectives」- Speakers
-
Keichiro Mihara（Fujita Health University International Center for Cell and Gene Therapy/Cellular Immunotherapies for Cancer）
- Speakers
-
Shigeki Ito（Division of Hematology and Oncology, Dept. of Internal Medicine, Iwate Medical University School of Medicine）
- Co-hosting
- Sanofi K.K.
Corporate Seminar 12024/06/01 (Saturday) 15:50ー16:40Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Hideto Tamura（Dokkyo Medical University Saitama Medical Center,Japan）
「Optimizing the outcome of newly diagnosed multiple myeloma」- Speakers
-
Gareth Morgan（New York University Langone）
- Co-hosting
- Janssen Pharmaceutical K.K.
Corporate Seminar 22024/06/01 (Saturday) 15:50ー16:40Venue 3 (4th floor 411/412)- Chairpersons
-
Yusuke Furukawa（Center for Medical Education,Teikyo University of Science）
「Role of carfilzomib for relapsed/refractory multiple myeloma in the immunotherapy era」- Speakers
-
Masuho Saburi（Oita Prefectural Hospital）
- Co-hosting
- ONO PHARMACEUTICAL CO., LTD.
Corporate Seminar 32024/06/02 (Sunday) 13:00ー13:50Venue 1 (International Conference Room, 5th floor)- Chairpersons
-
Shinsuke Iida（Dept. of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences）
「BCMA-targeted therapies: an update」- Speakers
-
Mohamad Mohty（Sorbone University, Saint-Antoine Hospital）
- Co-hosting
- Pfizer Japan
Corporate Seminar 42024/06/02 (Sunday) 13:00ー13:502nd venue (5th floor 502/503)- Chairpersons
-
Toshihiro Miyamoto（Kanazawa University Hematology）
「For physicians considering patient referral: Key factors influencing the safety, efficacy, and manufacturing of BCMA CAR T in clinical practic」- Speakers
-
Masaki Ri（Dept. of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences）
「How to Maximize the Benefits of BCMA CAR T Therapy: Insights from Real-World Clinical Experience」- Speakers
-
Satoshi Yoshihara（Dept. of Respiratory Medicine and Hematology, Hyogo Medical University）
- Co-hosting
- Bristol-Myers Squibb K.K. Japan Medical
2024年 5月31日（金）・6月1日（土）・6月2日（日）
- 会 場
- 福岡国際会議場
- 会 長
- 髙松 泰
MENU
